0.10Open0.10Pre Close0 Volume12 Open Interest12.50Strike Price0.00Turnover145.89%IV27.49%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0583Delta0.0317Gamma171.00Leverage Ratio-0.0258Theta-0.0002Rho-9.97Eff Leverage0.0029Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet